Apokyn (apomorphine hydrochloride subcutaneous injection – US WorldMeds, generic) — Cigna

Initial criteria

• Patient is experiencing 'off' episodes (examples include muscle stiffness, slow movements, or difficulty starting movements); AND
• Patient is currently receiving carbidopa/levodopa therapy; AND
• Patient has previously tried one other treatment for 'off' episodes and meets ONE of the following (i or ii):
• i. Patient had significant intolerance, according to the prescriber; OR
• ii. Patient had inadequate efficacy, according to the prescriber; AND
• The medication is prescribed by or in consultation with a neurologist

Approval duration

1 year